Stockhead’s Fraser Palamara sits down with Island Pharmaceuticals (ASX:ILA) CEO and managing director David Foster to get the short end of the long story on the company’s latest news.
Dual-listed (ASX and Nasdaq) regenerative medicine company Avita Medical (ASX:AVH) has seen its share price slide ~19% today on a downgrade of its earnings guidance. The fall was flagged before ASX ...
The "Dengue Fever - Global Clinical Trials Review, 2024" has been added to ResearchAndMarkets.com's offering.The clinical trial report provides an overview of the Dengue Fever Clinical trials scenario ...
INR:6957. france vs india football 1960 Enhua Pharmaceuticals received a warning letter from the FDA for selling defective products Aosaikang's subs ...